Drug Safety

Drug-Food Interactions in Hospitalised Patients: Methods of Prevention
pp. 383-393(11)
Authors: Gauthier I.; Malone M.

A Risk-Benefit Assessment of Irinotecan in Solid Tumours
pp. 395-417(23)
Authors: Siu L.L.; Rowinsky E.K.

A Risk-Benefit Assessment of Pharmacological Treatments for Panic Disorder
pp. 419-430(12)
Authors: Bennett J.A.; Moioffer M.; Stanton S.P.; Dwight M.; Keck P.E.J.

Minocycline-Induced Pigmentation: Incidence, Prevention and Management
pp. 431-440(10)
Authors: Eisen o.; Hakim M.D.

Drug Administration in Patients with Diabetes Mellitus: Safety Considerations
pp. 441-455(15)
Authors: Gilbert R.E.; Cooper M.E.; Krum H.

Pain Treatment in Multimorbid Patients, the Older Population and Other High-Risk Groups: The Clinical Challenge of Reducing Toxicity
pp. 457-472(16)
Author: Wilder-Smith C.H.